ASHPOfficial

In this two-part episode, presenters from the 2021 ASHP Midyear Clinical Meeting present real-world anticoagulation clinical cases and their reasoning and approach to managing their care.  In this episode, our patient-specific cases include inpatient management of a pulmonary embolism, management of coagulopathy with liver disease, and management of anticoagulants in acute kidney injury.

The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

Join Brittany Tschaen as she sits down with Joe Marchiano and Nancy Macdonald who will share their lessons learned and best practices for returning to in-person Midyear Clinical Meeting including navigating networking opportunities, attending live sessions and making the most of the full midyear experience.  Later in the episode, Brittany and Joe sit down with program chairs from the 2022 Midyear Clinical Meeting who will provide an exclusive preview into their presentations prior to the start of the Midyear Clinical Meeting.  

The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

In this two-part episode, presenters from the 2021 ASHP Midyear Clinical Meeting present real-world anticoagulation clinical cases and their reasoning and approach to managing their care. In this episode, our patient-specific cases include cancer-associated thrombocytopenia, spinal hematoma and apical thrombous.

The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

Interested in learning how to maximize your time at the Midyear Clinical Meeting? This podcast episode features two New Practitioners sharing their tips and tricks on how to successfully navigate the Midyear Clinical Meeting and Residency Showcase.

The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

In this featurette episode from the 2021 Midyear Clinical Meeting, listeners will learn about the “four D’s” of fluid therapy in appropriate fluid stewardship, review individual changes to fluid therapy that can improve patient outcomes, and hear about a real-world experience in developing a protocol and policy for the systemic adoption of fluid stewardship program. 

The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

This episode highlights the key takeaways from the 2021 Midyear Clinical Meeting on how pharmacists can apply data supporting pre-exposure prophylaxis (PrEP) and guideline-based testing to implement PrEP prescribing and monitoring into your existing practice.   

The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

In a sneak peak for the upcoming Midyear in Las Vegas, the SCSS Advisory Group on Emergency Medicine sits down with some can’t-miss educational session presenters to discuss what attendees can hope to learn about new and emerging areas of practice. 

The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

In honor of U.S. Antibiotic Awareness Week November 18-24, 2022, join us for a podcast discussion on the CDC National Healthcare Safety Network (NHSN) Antimicrobial Use (AU) Option. The availability of this Option is another opportunity to improve antimicrobial use for patient and public health.  

The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

In this featurette from the 2021 Midyear Clinical Meeting our content matter experts provide an overview of the ASPEN Lipid Injectable Emulsion Safety Recommendations and provide considerations and recommendations for prescribing, ordering review, preparation, administration, and monitoring for lipid injectable emulsions.

The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

Whether you are a first-year student exploring post-graduate opportunities or a fourth-year student trying to decide what is next, learn more about industry PharmD Fellowships. This podcast will cover the process of applying for a fellowship and what opportunities you can pursue during each stage of your pharmacy school training to prepare for a career in industry.  

The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.